Home Authors Posts by Adam Le
More capital was closed on for private equity secondaries in the first quarter of the year than for any other strategy outside of buyouts.
Investors that do not participate in GP-led opportunities could be incurring an opportunity cost of at least 15% over the long run.
In our final episode of Private Markets and the end of Cheap Money, we hear from IMCO, Oaktree Capital, BC Partners and more on what investment professionals there keep their eyes on in the era of higher borrowing costs.
Devon Park, which has also hired a Committed Advisors investment professional, aims to leverage its team's buyside experience in an increasingly crowded advisory market.
In this second episode of our miniseries Private Markets and the End of Cheap Money, we talk to LPs about allocation shifts, impacts on fundraising and what investors are looking for out of their GPs as rates rise.
Alex Mejia is joining Baird, less than 18 months after joining Goldman to advise on single- and double-asset GP-led deals.
The $46bn medical research endowment wants to be aligned with GPs who roll over and compound their exposure to assets rather than those who sell down, Robert Coke, head of buyout and residential property, tells PEI.
A lack of transparency in GP-led deals can backfire on general partners, says former ILPA chairman and CalPERS veteran Joncarlo Mark.
The secondaries community should take note of investors’ annoyance at unreasonable deadlines and the amount of work needed to make decisions on these deals.
UK head Olivier Decannière and former US head Benoît Verbrugghe are among those not listed as key people on the secondaries giant's ASF IX fund, which is seeking $15bn.
12Page 1 of 2